Log In
Print this Print this

tobramycin inhaled solution (Bethkis)

  Manage Alerts
Collapse Summary General Information
Company Chiesi Farmaceutici S.p.A.
DescriptionInhaled tobramycin solution
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationRespiratory infection
Indication DetailsTreat pseudomonas aeruginosa infection in cystic fibrosis (CF) patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today